Rhonda : In the U.S
POMC, PCSK1, and LEPR Deficiency (Adults and Pediatric Patients Aged 6 Years and Older) The safety of IMCIVREE was evaluated in two 52-week, open-label clinical trials of 27 patients aged 6 years and older with obesity due to POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPRgenes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (Trial 3 and Trial 4) [see Clinical Studies (14.3)]
Most people don't understand placebo blinded randomized trials
Consequently, novel anticancer drugs may target these transporters
For Product Inquiry call 1-800-417-9175 Manufactured for: Somerset Therapeutics, LLC Somerset, NJ 08873 Made in India Code No.: KR/DRUGS/KTK/28/289/97 ST-CYC/P/06 Revised: 04/2025 1201236 1 mL Container Label NDC 70069-005-01 Container Label 1 mL Carton Label NDC 70069-005-10 Carton Label 10 mL Container Label NDC 70069-172-01 container Label 10 mL Carton Label Pack of 10's NDC 70069-172-10 carton label 10 mL Carton Label Pack of 25's NDC 70069-172-25 carton-label
